151 related articles for article (PubMed ID: 18627046)
1. Matrix extracellular phosphoglycoprotein (MEPE) correlates with serum phosphorus prior to and during octreotide treatment and following excisional surgery in hypophosphatemic linear sebaceous nevus syndrome.
Hoffman WH; Jain A; Chen H; Fedarko NS
Am J Med Genet A; 2008 Aug; 146A(16):2164-8. PubMed ID: 18627046
[No Abstract] [Full Text] [Related]
2. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome.
Hoffman WH; Jueppner HW; Deyoung BR; O'dorisio MS; Given KS
Am J Med Genet A; 2005 Apr; 134(3):233-6. PubMed ID: 15742370
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density.
Jain A; Fedarko NS; Collins MT; Gelman R; Ankrom MA; Tayback M; Fisher LW
J Clin Endocrinol Metab; 2004 Aug; 89(8):4158-61. PubMed ID: 15292364
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein Levels in Healthy Children and, Pregnant and Puerperal Women.
Ozsen A; Furman A; Guran T; Bereket A; Turan S
Horm Res Paediatr; 2019; 92(5):302-310. PubMed ID: 32187608
[TBL] [Abstract][Full Text] [Related]
5. Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets.
Bresler D; Bruder J; Mohnike K; Fraser WD; Rowe PS
J Endocrinol; 2004 Dec; 183(3):R1-9. PubMed ID: 15590969
[TBL] [Abstract][Full Text] [Related]
6. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
Garringer HJ; Fisher C; Larsson TE; Davis SI; Koller DL; Cullen MJ; Draman MS; Conlon N; Jain A; Fedarko NS; Dasgupta B; White KE
J Clin Endocrinol Metab; 2006 Oct; 91(10):4037-42. PubMed ID: 16868048
[TBL] [Abstract][Full Text] [Related]
7. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
8. Epidermal nevus syndrome associated with hypophosphatemic rickets.
Moreira AI; Ferreira G; Santos M; Baptista A; Ferreira EO
Dermatol Online J; 2010 Sep; 16(9):14. PubMed ID: 20875335
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
10. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia.
Liu S; Brown TA; Zhou J; Xiao ZS; Awad H; Guilak F; Quarles LD
J Am Soc Nephrol; 2005 Jun; 16(6):1645-53. PubMed ID: 15843468
[TBL] [Abstract][Full Text] [Related]
11. Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23.
Narazaki R; Ihara K; Namba N; Matsuzaki H; Ozono K; Hara T
Pediatr Nephrol; 2012 May; 27(5):861-3. PubMed ID: 22205508
[TBL] [Abstract][Full Text] [Related]
12. Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth.
Salmon B; Bardet C; Coyac BR; Baroukh B; Naji J; Rowe PS; Opsahl Vital S; Linglart A; Mckee MD; Chaussain C
Connect Tissue Res; 2014 Aug; 55 Suppl 1():79-82. PubMed ID: 25158186
[TBL] [Abstract][Full Text] [Related]
13. [Rickets].
Yasuda T
Clin Calcium; 2009 Jan; 19(1):109-16. PubMed ID: 19122271
[TBL] [Abstract][Full Text] [Related]
14. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.
Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL
Genomics; 2000 Jul; 67(1):54-68. PubMed ID: 10945470
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia.
Habra MA; Jimenez C; Huang SC; Cote GJ; Murphy WA; Gagel RF; Hoff AO
Endocr Pract; 2008 Dec; 14(9):1108-14. PubMed ID: 19158050
[TBL] [Abstract][Full Text] [Related]
16. Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone.
Argiro L; Desbarats M; Glorieux FH; Ecarot B
Genomics; 2001 Jun; 74(3):342-51. PubMed ID: 11414762
[TBL] [Abstract][Full Text] [Related]
17. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
18. Hemispherectomy in a premature neonate with linear sebaceous nevus syndrome.
Winston KR; Kang J; Laoprasert P; Kleinschmidt-DeMasters BK
Pediatr Neurosurg; 2008; 44(2):159-64. PubMed ID: 18230933
[TBL] [Abstract][Full Text] [Related]
19. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
Zhang GX; Mizuno M; Tsuji K; Tamura M
Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
[TBL] [Abstract][Full Text] [Related]
20. [Nevus sebaceous of Jadassohn: implications of the size and location on treatment].
Suárez-Amor O; Cabanillas M; León-Muiños E; Monteagudo B; de las Heras C
An Pediatr (Barc); 2009 Dec; 71(6):586. PubMed ID: 19836322
[No Abstract] [Full Text] [Related]
[Next] [New Search]